Olema Pharmaceuticals, Inc.

As of June 17, 2025, Olema Pharmaceuticals, Inc. shows a mildly bearish trend overall, with daily moving averages indicating bearishness, while weekly indicators suggest mild bullishness, but monthly signals remain predominantly bearish, warranting caution.

Olema Pharmaceuticals, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $30 million and a market cap of $274.37 million. Key metrics include a negative P/E ratio, a 0.00% dividend yield, and a debt-to-equity ratio of -1.02.

As of Jun 18, Olema Pharmaceuticals, Inc. has a market capitalization of 274.37 million and reported net sales of 0.00 million with a net profit of -128.89 million over the latest four quarters. Shareholder's funds are at 408.96 million and total assets at 556.07 million.